By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

Magazine Rate

Helping Businesses Grow With Trusted Knowledge

  • Business
    • Startups
    • Marketing
    • Management
    • Business News
  • Tech
    • Automation
  • Finance
    • Crypto
  • E-commerce
    • Innovation
  • Fashion
    • Beauty
  • Biography
    • Celebrity
  • Health
    • Food
  • Blog
    • Travel
    • Game
    • Sport
    • Home Improvement
Reading: FRABOC Explained: Australia’s Retired Breast & Ovarian Cancer Risk Tool — and What Replaced It
Share
Font ResizerAa

Magazine Rate

Helping Businesses Grow With Trusted Knowledge

Font ResizerAa
  • Business
  • Tech
  • Finance
  • E-commerce
  • Fashion
  • Biography
  • Business
  • Tech
  • Finance
  • E-commerce
  • Fashion
  • Biography
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Home » Blog » FRABOC Explained: Australia’s Retired Breast & Ovarian Cancer Risk Tool — and What Replaced It
Health

FRABOC Explained: Australia’s Retired Breast & Ovarian Cancer Risk Tool — and What Replaced It

MagazineRate Team
Last updated: November 9, 2026 5:54 pm
MagazineRate Team
2 months ago
Share
FRABOC Explained: Australia's Retired Breast & Ovarian Cancer Risk Tool — and What Replaced It
FRABOC Explained: Breast & Ovarian Cancer Risk Guide
SHARE

If you have found the word “Fraboc” in an old medical leaflet, a referral letter or a health website, you may be wondering where this tool has gone. FRABOC was an Australian online tool that helped doctors and nurses judge a woman’s risk of breast and ovarian cancer from her family history. It was run by Cancer Australia, the national cancer agency — and it no longer exists.

Contents
What FRABOC Stood ForHow the Tool WorkedWhat FRABOC Was NotIs FRABOC Still Available?What Replaced FRABOC: iPreventWhy Family History Matters So MuchYour Father’s Side Counts TooOne Relative Does Not Automatically Mean High RiskThe Three Risk Categories, in Plain WordsBRCA1 and BRCA2, in Simple WordsWhat to Gather Before You Talk to a GPOld Pages, Dead Links and Look-Alike CalculatorsScreening, and What Happens at Each Risk LevelWhen to Talk to Your GPConclusionFAQsIs FRABOC still available in Australia?What does FRABOC stand for?What replaced FRABOC?Does having one relative with breast cancer mean I am high risk?Can a risk assessment tool tell me whether I have cancer?

This guide explains, in simple words, what FRABOC was, how it worked, why it was retired, and what replaced it. Just as important, it explains the idea that made FRABOC useful, because that idea is still at the heart of cancer care today: a carefully collected family history can show who is at average risk, who needs a closer look, and who should be referred to a specialist. A risk tool never diagnoses cancer — but it can start the right conversation at the right time.

🔗 You may also like:
Tampons: A Practical Guide to Use, Absorbency, Safety and Comfort
RN Fundamentals 2016 70 Questions: A Complete Practice and Study Guide

What FRABOC Stood For

FRABOC — usually written FRA-BOC — stands for Familial Risk Assessment – Breast and Ovarian Cancer. Each part of the name did a job. “Familial” meant the tool was built on family history. “Risk assessment” meant it estimated the chance of future cancer; it did not test for cancer itself. And “breast and ovarian” named the two cancers it covered, because the same inherited gene changes can raise the risk of both.

The tool lived on the Cancer Australia website and was designed for health professionals — mainly GPs and nurses — to use during a consultation. A patient would not normally have filled it in alone at home. The doctor or nurse entered the family details, and the tool helped them place the woman into a risk category and decide what should happen next: normal screening, a more detailed assessment, or referral to a family cancer clinic.

How the Tool Worked

FRABOC did not ask a single question such as “did your mother have breast cancer?” It looked at the pattern of cancer across the family. The details that mattered were the same ones specialists still ask about today: which relatives had cancer, what type of cancer it was, how closely they were related, and how old they were when they were diagnosed.

Pattern is everything in this field. One aunt diagnosed with breast cancer at 78 is, on its own, a common event in a common disease. Several close relatives with breast or ovarian cancer, diagnosed young, on the same side of the family, tell a very different story — one that can point to an inherited gene change running through the family. Older Cancer Australia guidance sent professionals to FRABOC exactly for those harder cases, where a printed table was not detailed enough to judge the pattern fairly.

The result was a category, not a prediction. FRABOC helped the professional say whether a woman’s family history put her at roughly average risk, at moderately increased risk, or at potentially high risk — and Australian guidance attached different next steps to each level.

What FRABOC Was Not

Because the name sounds technical, it is worth clearing away three misunderstandings. FRABOC was not a screening test: it took no scan, no blood and no tissue. It was not a genetic test: it never looked at anyone’s DNA, though its result could lead a doctor to suggest genetic counselling. And it was not a diagnosis: it said something about future risk, nothing about whether cancer was present.

Keeping those lines clear matters when you read about health topics online. There is a real difference between an official clinical tool run by a national agency and a website that simply writes about health — the same difference we drew in our guide to Brasssmile com, a health-content website that is not a dental clinic. Articles can explain; only professionals and validated tools can assess.

Is FRABOC Still Available?

No. Cancer Australia now lists FRA-BOC as a former tool and states plainly that it is no longer available on its website. The calculator itself has been withdrawn. What remains is traces: old PDFs, training documents, journal articles and clinic pages that still mention it, because for years it was the standard address for this job in Australia. A medical journal article from 2014, for example, directed GPs to FRA-BOC as the tool for assessing a family history of breast cancer — good advice then, a dead end now.

So if a website today offers you a working “FRABOC calculator”, be careful. It is either describing the old tool as if it were current, or it is an unofficial copy using the name. Neither is the Cancer Australia tool, and neither should be trusted with your family’s medical details.

What Replaced FRABOC: iPrevent

The main modern replacement is iPrevent, an online breast cancer risk assessment tool developed by a multidisciplinary team at the Peter MacCallum Cancer Centre in Melbourne, one of Australia’s leading cancer hospitals. iPrevent was built for women and their doctors to use together, and it shows how far the science has moved since FRABOC.

The biggest change is breadth. FRABOC looked at family history almost on its own. iPrevent still collects a detailed family history — breast, ovarian, pancreatic and prostate cancers among relatives, with ages at diagnosis — but it also asks about the woman herself: her medical history, previous breast biopsies or benign breast disease, reproductive history, hormone use, height, weight and lifestyle factors. It then runs those details through two long-validated risk models, known as IBIS and BOADICEA, and produces an estimate of her risk over the next ten years and over her remaining lifetime.

A few practical points are worth knowing. iPrevent is meant for women who have not had invasive breast cancer or DCIS (ductal carcinoma in situ) — it assesses the risk of a first cancer, not a returning one. It takes roughly half an hour to complete properly, because the family details matter. And no personal information is saved once the session ends. The output is a report designed to be taken to a doctor, because — exactly as with FRABOC — the number is the start of a conversation, not an answer by itself.

Why Family History Matters So Much

Most breast and ovarian cancers are not inherited. They happen for a mix of reasons — age, hormones, lifestyle, chance — in women with no family pattern at all. Only a small minority are linked to an inherited faulty gene passed down through a family. The whole point of family-history assessment is to find that minority early, because they are the women who can gain the most from extra screening, prevention options and specialist care.

Certain patterns raise a flag. Several blood relatives with breast or ovarian cancer, especially on the same side of the family. Cancers diagnosed at unusually young ages. A relative who had both breast and ovarian cancer. Breast cancer in a male relative, which is rare and therefore significant. A known faulty gene, such as BRCA1 or BRCA2, already found in the family. One flag on its own may mean little; flags together are what tools like FRABOC were built to weigh.

Your Father’s Side Counts Too

The most common mistake in family-history thinking is to count only mothers, sisters and aunts. Inherited gene changes pass through men as well as women. A father can carry a BRCA gene change and pass it to his daughter, even if he never develops a related cancer himself. His mother, his sisters and his aunts are part of the picture.

Cancer Council Australia is explicit about this: when you think about family cancer history, look at both sides of the family. When you gather information for a GP appointment, ask about your father’s relatives as carefully as your mother’s. Gaps are normal — families lose touch, older generations died young of other causes, records were never kept. Share what you know, say honestly what you do not, and let the professional judge what the incomplete picture can and cannot show.

One Relative Does Not Automatically Mean High Risk

This is the reassurance many readers come looking for, and the evidence supports it. Breast cancer is common — common enough that many families will see a case in an older relative purely by chance, with no inherited cause behind it. One relative diagnosed later in life, with no other pattern around her, usually leaves the rest of the family close to average risk.

What moves a family out of the average group is the pattern described above: numbers, closeness, ages and types of cancer, taken together. That is precisely why a structured assessment beats worry-driven guessing. A GP with the full picture can often reassure; and when the picture genuinely deserves it, the same GP can refer on — to genetic counselling or a family cancer clinic — rather than leaving a woman to interpret a search result alone.

The Three Risk Categories, in Plain Words

Australian guidance, used in the FRABOC era and still used with modern tools, sorts family-history risk into three broad categories. Category 1 means at or slightly above average risk — the large majority of women. Standard population screening is usually the right plan. Category 2 means moderately increased risk — the family pattern is stronger than average, and a GP may suggest a more careful screening routine or a clarifying assessment. Category 3 means potentially high risk — a pattern that suggests a possible inherited gene change, where referral to a family cancer clinic is the recommended step.

Two things about categories are easy to misunderstand. First, a category is a comparison with the average woman, not a promise about you personally: “potentially high risk” does not mean cancer is likely, and “average risk” does not mean immunity. Second, categories can change. A new diagnosis in the family, or a genetic test result, can move a woman’s assessment — one reason family history is worth updating with your GP over the years, not settling once and forgetting.

BRCA1 and BRCA2, in Simple Words

BRCA1 and BRCA2 are genes that everyone has. In their normal form they help protect against cancer by repairing damaged DNA. Some people inherit a changed (faulty) version of one of these genes. The faulty version does that repair job poorly, so breast and ovarian cancers become much more likely over a lifetime — though never certain.

A faulty BRCA gene is the best-known cause of hereditary breast and ovarian cancer, but it is not the only one, and most women with a family history do not carry one. Genetic testing is therefore not offered to everyone with an affected relative. It is generally considered when the personal or family pattern gives a real chance of finding a change — the kind of pattern that lands a woman in Category 3. Testing usually starts, where possible, with a relative who has had cancer, because that gives the clearest result for the whole family. This is specialist territory: a family cancer clinic will explain the benefits, the limits and the possible effects on relatives before any test is done.

What to Gather Before You Talk to a GP

You can make a risk conversation far more useful by arriving with the raw material organised. For each relative you know about, note: their relationship to you, the type of cancer, and roughly how old they were when diagnosed. Cover both sides of the family. Add anything you know about genetic testing in the family — and if a relative has an actual test report, that document is worth far more than a remembered summary of it.

Think of it as building a small, careful file on one subject before an important decision — the same patient habit behind preparing a research dossier on a company before trusting it. Dates can be approximate; “about 50” is far better than nothing. If family details are hard to get — adoptions, estrangements, early deaths — write down that they are unknown. A GP would rather work from an honest partial record than a confident guess.

Old Pages, Dead Links and Look-Alike Calculators

FRABOC’s afterlife carries a general warning. Retired tools leave fossils online: old clinic PDFs that still recommend them, training slides, forum answers, and explainer articles written years ago and never updated. Broad multi-topic websites repeat the problem — a general site in the style of Domikyo.com, which publishes across technology, business, finance and health, may carry a page describing FRABOC as a current resource simply because nobody revisited it.

Protect yourself the way you would with any official service: check that you are on the genuine website before trusting or typing anything. Our guide to how to research a company’s real website address sets out the checking routine, and it applies to health services exactly as it does to banks. Family cancer history is sensitive information. It belongs in a consultation, or in a current official tool that states how it handles your data — not in a copycat “calculator” on a site you cannot identify.

🔗 You may also like:
Brasssmile com Explained: A Simple Guide to Braces, Aligners and Dental Care
Research Dossier for a Target Company: How to Build a Complete Company Intelligence Report

Screening, and What Happens at Each Risk Level

For women at average risk, Australia runs one of the world’s established screening programmes: BreastScreen Australia provides free mammograms, with women aged 50 to 74 actively invited every two years (women in their 40s, and older women, can also attend free). Screening is for women without symptoms — a new lump or change should always go straight to a doctor rather than waiting for a screening appointment.

At moderately increased risk, a GP may suggest a tighter routine: screening that starts earlier or happens more often, sometimes with an updated formal assessment as the family picture changes. At potentially high risk, the family cancer clinic takes the lead. Depending on the person, options discussed there can include more intensive screening such as MRI alongside mammograms, genetic testing, and — for the highest-risk women — risk-reducing medication or surgery. These are serious, personal decisions made slowly with specialists; no article and no calculator makes them for you.

Ovarian cancer is handled differently, for a simple reason: there is currently no effective screening test for it in the general population. That is exactly why family history carries so much weight for this cancer — a strong pattern leads to genetic assessment and an individual plan, rather than a routine test that does not exist.

When to Talk to Your GP

Book the conversation if any of these sound familiar: several relatives on the same side of the family with breast or ovarian cancer; any of them diagnosed young, particularly under 50; a relative with both breast and ovarian cancer; a male relative with breast cancer; or a known gene change already identified in your family. Also book it if you simply do not know your family history and the not-knowing worries you — uncertainty is a legitimate reason to ask.

Bring the notes described above, expect questions rather than instant answers, and expect the possibility of referral rather than a verdict on the day. Risk assessment done properly is a process: family history first, category second, plan third. FRABOC supported the second step of that process for Australian GPs for years. The tool has retired; the process has not.

Medical note: this article is general information only. It is not medical advice and cannot assess your personal risk. If you are concerned about your family history or notice any breast change, see your GP or a qualified health professional.

Conclusion

FRABOC was Cancer Australia’s online Familial Risk Assessment tool — a structured way for GPs and nurses to turn a woman’s family history of breast and ovarian cancer into a risk category and a sensible next step. It has been retired and is no longer available, whatever old pages still claim. Its modern successor, Peter Mac’s iPrevent, does the same job with a wider set of factors and validated models behind it. The lasting lesson of FRABOC is not the tool but the method: collect the family history carefully, on both sides, with ages and cancer types; read the pattern rather than any single case; and let professionals turn that pattern into a plan. If cancer appears in your family more than chance would explain, that conversation with a GP is worth having — and it is worth having with the facts in hand.

FAQs

Is FRABOC still available in Australia?

No. FRABOC (FRA-BOC) has been retired. Cancer Australia, which ran the tool, lists it as a former resource and states that it is no longer available on its website. Pages or PDFs that still point to it are out of date, and any “FRABOC calculator” offered elsewhere is not the official tool. Current assessment uses newer tools such as iPrevent, through or alongside your GP.

What does FRABOC stand for?

FRABOC stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was an online tool that helped Australian health professionals estimate a woman’s risk of those cancers from the pattern of cancer in her family — which relatives were affected, with which cancers, and at what ages.

What replaced FRABOC?

The main replacement is iPrevent, developed at the Peter MacCallum Cancer Centre in Melbourne. It assesses breast cancer risk using the validated IBIS and BOADICEA models, combining family history with personal, reproductive and lifestyle factors to give ten-year and lifetime estimates, plus guidance to discuss with a doctor. GPs can also direct women to family cancer clinics when the pattern suggests a possible inherited risk.

Does having one relative with breast cancer mean I am high risk?

Usually not. Breast cancer is common, and a single case in an older relative often happens by chance with no inherited cause. Risk rises when there is a pattern — several close relatives, diagnoses at young ages, ovarian cancer in the family, male breast cancer, or a known faulty gene such as BRCA1 or BRCA2. A GP can weigh the whole pattern instead of any single case.

Can a risk assessment tool tell me whether I have cancer?

No. Tools like FRABOC and iPrevent estimate the chance of developing cancer in the future; they cannot detect or diagnose cancer that is present now. Screening tests such as mammograms look for existing cancer, and symptoms or changes should always be checked by a doctor promptly. A risk estimate and a diagnosis are two completely different things.

Goutabio Explained: What It Is, Its Origins, Supplement Claims, and Safety Facts
Spiritualhubz.com USA: Spiritual Meanings and Dream Guide
5 Retirement Decisions That Protect Quality of Life
Best Cosmetic Surgery in Turkey: Achieving Natural Results at Affordable Costs
Brasssmile: Simple Ways to Understand Oral Health and Daily Dental Care
TAGGED:breast cancer risk assessment Australiafamilial breast cancer riskFRA-BOC explainedFRABOCFRABOC Australia
Share This Article
Facebook Email Print
Previous Article What Is Babeltee? The Mystery Tea Term the Internet Can't Quite Define What Is Babeltee? The Mystery Tea Term the Internet Can’t Quite Define
Next Article Jipinfeiche Explained: The Chinese Name for Need for Speed and What It Means Jipinfeiche Explained: The Chinese Name for Need for Speed and What It Means
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
PinterestPin
InstagramFollow
YoutubeSubscribe
Popular News
What Is Wixtee? A Practical Guide to Its Purpose, Uses, and Potential Benefits
Business

What Is Wixtee? A Practical Guide to Its Purpose, Uses, and Potential Benefits

MagazineRate Team
By MagazineRate Team
1 month ago
Yenkly Com: What It Is, Content, Topics, and Key Features
Thoughtful Ways to Surprise Loved Ones on Any Occasion
What Is Boelis? A Detailed Look at Its Meaning, Background, and Digital Presence
Safebooru Explained: A Complete Guide to Anime Image Search
Business Knowledge Hub

More Information:Magazine Rate

MagazineRate

MagazineRate is your trusted source for business insights, startup strategies, marketing trends, finance tips, and innovation to help entrepreneurs and businesses grow successfully.

Categories

  • Business
  • Tech
  • Finance
  • E-commerce
  • Fashion
  • Biography

About

  • About us
  • Contact us
  • Privacy Policy
  • Terms and Condition
  • Disclaimer

Find Us on Socials

Copyright © 2026 Magazinerate. All rights reserved. Made with passion for Business.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?